Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma

Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma

Xudong Zhu,1,2,* Xingming Zhang,1,2,* Guangxi Sun,1,2,* Zhenhua Liu,1,2,* Haoran Zhang,1,2 Yaojing Yang,1,2 Yuchao Ni,1,2 Jindong Dai,1,2 Sha Zhu,1,2 Junru Chen,1,2 Jinge Zhao,1,2 Zhipeng Wang,1,2 Hao Zeng,1,2 Pengfei Shen1,2 1Department of Urology, West China Hospita...

Full description

Bibliographic Details
Main Authors: Zhu X, Zhang X, Sun G, Liu Z, Zhang H, Yang Y, Ni Y, Dai J, Zhu S, Chen J, Zhao J, Wang Z, Zeng H, Shen P
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Cancer Management and Research
Subjects:
sunitinib
plasma concentration
metastatic renal cell carcinoma
individualized schedule adjustment
clinical outcomes
Online Access:https://www.dovepress.com/efficacy-and-safety-of-individualized-schedule-of-sunitinib-by-drug-mo-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/efficacy-and-safety-of-individualized-schedule-of-sunitinib-by-drug-mo-peer-reviewed-fulltext-article-CMAR

Similar Items